InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Triola Anna Diaz, Directeur commercial. Officer active across 1 companies, notably Entasis Therapeutics Holdings Inc.. Cumulatively, 2 disclosures have been recorded. The latest transaction was filed on 18 January 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
0125,000 shares0
Common Stock
SEC:0001104659-22-005407·
0125,000 shares0
Common Stock
SEC:0001104659-22-005407:0·
2 of 2 declarations
About Triola Anna Diaz
Anna Diaz Triola is the Chief Commercial Officer at Entasis Therapeutics Holdings Inc. She is responsible for commercial strategy and business development, aiming to maximize the company's growth and market impact. Her expertise in marketing and sales is crucial for achieving business objectives.
